AI-powered microscope could help surgeons spot skin cancer cells in real time
NCT ID NCT06600165
First seen Sep 30, 2025
Summary
This study tests whether artificial intelligence can help surgeons analyze microscope images of skin cancer tissue during surgery. The goal is to give surgeons instant feedback on whether they have removed all the cancer cells. The trial will enroll 1,000 patients with basal cell carcinoma, the most common type of skin cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinic and Policlinic of Dermatology and Allergy, LMU Munich
RECRUITINGMunich, Bavaria, 80337, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ex vivo confocal microscopy with AI analysis
What this could lead to
If successful, this could give surgeons real-time feedback during skin cancer removal, making surgery more precise and reducing the chance of leaving cancer behind.
What could go wrong
This is a large but early-stage feasibility study focused on image analysis, not patient outcomes. The AI may not yet be accurate enough for routine use, and results may not change surgical success rates.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.